
Agentic AI Models and Rethinking Pharma Field Teams
Pharma field forces face three key challenges: scaling services beyond tier one, shifting from reactive to proactive engagement, and empowering teams with agentic AI.
Pharmaceutical Executive spoke with Ankit Jain, CEO and founder of Infinitus, about how agentic AI models are being deployed across the pharma and biotech industries. The conversation focused on how these models are helping manage teams more efficiently.
Jain discussed these models have the potential to reshape the industry’s commercial model by providing both field teams and physicians with a wider array of tools and communication options.
He also explained why these models must start delivering results that go beyond just productivity benefits and start delivering broader changes to the industry.
Pharmaceutical Executive: How can agentic AI help pharma rethink how it deploys its field forces?
Ankit Jain: As the pharma field force rethinks how to best serve its customers — whether healthcare providers, infusion centers, or the broader network helping deliver medications — three questions keep coming up.
First, how do you extend the services you offer tier one provider networks to tier two and tier three? How do you scale your offerings to support everyone? Second, how do you become more proactive instead of reactive? Today, most of the field is reacting to someone pounding the table. How can pharma be available 24/7 and, when a specific situation arises, proactively engage the entire network before escalations happen?
And third, as everyone figures out how to upskill their teams — both in productivity and capabilities — how can agentic technology empower each field force member? Whether it’s a salesperson or a field reimbursement manager, they need more knowledge and more data at their fingertips. Agentic solutions like our field force platform are making that possible.
Related to this article








